Quest PharmaTech (QPT) Stock Chart & Stock Price History → Move Your Money Before May 22 (From Stansberry Research) (Ad) Free QPT Stock Alerts C$0.02 -0.02 (-42.86%) (As of 04/25/2024 05:18 PM ET) Add Compare Share Share ChartStock AnalysisChartEarningsHeadlinesInsider TradesStock AnalysisChartEarningsHeadlinesInsider Trades Quest PharmaTech Stock Price Performance5 Day Performance-42.86%1 Month Performance-20.00%3 Month Performance-33.33%6 Month Performance-69.23%Year-To-Date Performance-63.64%1 Year Performance-73.33% Receive QPT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Stansberry ResearchMove Your Money Before May 22The SIX WORDS That Could Destroy America... And The Value of Your Savings. He predicted the dangerous rise of inflation... the death of the 60/40 portfolio... and now, this 40-year market veteran and retirement expert is stepping forward with a new must-see warning for every American. It involves the world's most powerful investors, central bankers, and America's most bitter geopolitical rivals. Here's where Dr. David Eifrig says to move your money immediately. QPT Stock Chart for Friday, April, 26, 2024 QPT Chart by TradingView Quest PharmaTech Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization04/25/2024C$0.04C$0.02-42.86%C$0.02C$0.027,000 shsC$3.38 million04/24/2024C$0.04C$0.04C$0.04C$0.0413,500 shsC$5.92 million04/23/2024C$0.04C$0.04C$0.04C$0.0413,500 shsC$5.92 million04/22/2024C$0.04C$0.04C$0.04C$0.0413,500 shsC$5.92 million04/19/2024C$0.03C$0.04+16.67%C$0.04C$0.0413,500 shsC$5.92 million04/18/2024C$0.03C$0.03C$0.03C$0.031,000 shsC$5.07 million Get the Latest News and Ratings for QPT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. 04/17/2024C$0.03C$0.03C$0.03C$0.031,000 shsC$5.07 million04/16/2024C$0.03C$0.03C$0.03C$0.031,000 shsC$5.07 million04/15/2024C$0.03C$0.03C$0.03C$0.031,000 shsC$5.07 million04/12/2024C$0.04C$0.03-14.29%C$0.03C$0.034,000 shsC$5.07 million04/11/2024C$0.04C$0.04C$0.04C$0.0441,786 shsC$5.92 million04/10/2024C$0.04C$0.04C$0.04C$0.0441,786 shsC$5.92 million04/09/2024C$0.03C$0.04+40.00%C$0.04C$0.0349,000 shsC$5.92 million04/08/2024C$0.03C$0.03-16.67%C$0.03C$0.0325,750 shsC$4.23 million04/05/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$5.07 million04/04/2024C$0.03C$0.03+20.00%C$0.03C$0.032,000 shsC$5.07 million04/03/2024C$0.03C$0.03-16.67%C$0.03C$0.0311,000 shsC$4.23 million04/02/2024C$0.03C$0.03C$0.03C$0.031,000 shsC$5.07 million04/01/2024C$0.03C$0.03+20.00%C$0.03C$0.036,393 shsC$5.07 million03/29/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/28/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/27/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/26/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/25/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/22/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/21/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/20/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/19/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/18/2024C$0.03C$0.03C$0.03C$0.0312,000 shsC$4.23 million03/15/2024C$0.03C$0.03C$0.03C$0.0310,000 shsC$4.23 million03/14/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/13/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/12/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/11/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/08/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/07/2024C$0.03C$0.03C$0.04C$0.0379,000 shsC$4.23 million03/06/2024C$0.03C$0.03-16.67%C$0.04C$0.0379,000 shsC$4.23 million03/05/2024C$0.03C$0.03C$0.03C$0.0318,000 shsC$5.07 million03/04/2024C$0.03C$0.03+20.00%C$0.03C$0.0318,000 shsC$5.07 million03/01/2024C$0.03C$0.03C$0.03C$0.0310,000 shsC$4.23 millionThe Next Step of Their Control Is Here … (Ad)Earlier this week, Section 702 of the Foreign Intelligence Surveillance Act (FISA) was renewed for an additional two years. What does this mean? It means the government has more time — and more ways — to surveil and control you.4 simple steps to protect your privacy and money before it’s too late.02/29/2024C$0.03C$0.03C$0.03C$0.035,000 shsC$4.23 million02/28/2024C$0.03C$0.03C$0.03C$0.035,000 shsC$4.23 million02/27/2024C$0.03C$0.03C$0.03C$0.035,000 shsC$4.23 million02/26/2024C$0.03C$0.03C$0.03C$0.035,000 shsC$4.23 million02/23/2024C$0.03C$0.03C$0.03C$0.035,000 shsC$4.23 million02/22/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/21/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/20/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/19/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/16/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/15/2024C$0.03C$0.03C$0.03C$0.032,000 shsC$4.23 million02/14/2024C$0.03C$0.03C$0.03C$0.033,000 shsC$4.23 million02/13/2024C$0.03C$0.03C$0.03C$0.0315,000 shsC$4.23 million02/12/2024C$0.03C$0.03C$0.03C$0.0315,000 shsC$4.23 million02/09/2024C$0.03C$0.03C$0.03C$0.0340,100 shsC$4.23 million02/08/2024C$0.02C$0.03+25.00%C$0.03C$0.0342,000 shsC$4.23 million02/07/2024C$0.03C$0.02-20.00%C$0.02C$0.027,000 shsC$3.38 million02/06/2024C$0.03C$0.03C$0.03C$0.0227,219 shsC$4.23 million02/05/2024C$0.03C$0.03C$0.03C$0.0227,219 shsC$4.23 million02/02/2024C$0.03C$0.03C$0.03C$0.0227,220 shsC$4.23 million02/01/2024C$0.03C$0.03C$0.03C$0.0227,220 shsC$4.23 million01/31/2024C$0.03C$0.03-16.67%C$0.03C$0.0227,220 shsC$4.23 million01/30/2024C$0.03C$0.03C$0.03C$0.039,600 shsC$5.07 million01/29/2024C$0.03C$0.03C$0.03C$0.039,600 shsC$5.07 million01/26/2024C$0.02C$0.03+50.00%C$0.03C$0.0345,000 shsC$5.07 million01/25/2024C$0.02C$0.02C$0.02C$0.0217,000 shsC$3.38 million Related Companies: IOT Stock Chart HEM Stock Chart AEZS Stock Chart ATE Stock Chart RVX Stock Chart SBM Stock Chart KNE Stock Chart CZO Stock Chart TMD Stock Chart VM Stock Chart Receive QPT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Quest PharmaTech and its competitors with MarketBeat's FREE daily newsletter. This page (CVE:QPT) was last updated on 4/26/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThese AI trades triggered this morning (545% return)Prosper Trading AcademyExposed: 10 CENT Crypto to Explode April 20th?True Market InsidersThe A.I. story nobody is telling you (Read ASAP)TradeSmithForget AI, Imperium Is Expected to Grow 320,00% in 3 YearsBanyan Hill PublishingProtect Your Bank Account Before It’s Too LateWeiss RatingsMan Who Predicted 2008: “This Will be Worse.”AltimetryEmergency: Biden's $20 Trillion Mistake Could Cost YOU!GoldenCrest Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Quest PharmaTech Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
